Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Gross Profit Growth (5y) (2017 - 2026)

Analysis

Iqvia Holdings (IQV) Gross Profit Growth (5y) (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.18%
Mar 31, 2026 3.96%
Dec 31, 2025 4.98%
Sep 30, 2025 6.85%
Jun 30, 2025 10.12%
Mar 31, 2025 6.90%
Dec 31, 2024 17.59%
Sep 30, 2024 19.60%
Jun 30, 2024 18.73%
Mar 31, 2024 18.39%
Dec 31, 2023 19.73%
Sep 30, 2023 19.44%
Jun 30, 2023 20.02%
Mar 31, 2023 18.49%
Dec 31, 2022 26.15%
Sep 30, 2022 19.05%
Jun 30, 2022 20.46%
Mar 31, 2022 19.31%
Dec 31, 2021 23.49%
Sep 30, 2021 33.94%